Mike Ravenscroft
Angel Investor @ University System of Maryland Momentum Fund
Washington, United States
Mike Ravenscroft is a Series A investor at University System of Maryland Momentum Fund in Washington focused on Health Care and AgTech. Mike manages the day-to-day operations of the PeaceTech Accelerator in Washington, D.C. and oversees C5 Accelerate’s domestic portfolio of early stage investments. In this capacity, he works with C5’s network of mentors, partners, and investors to help its network of entrepreneurs scale their businesses. Prior to joining C5, Mike was Director ofthe MACH37 Cyber Accelerator and was on the Investment Team at CIT GAP Funds, a non-profit venture capital fund in Herndon, VA. While at CIT, Mike helped launch the EMERGE accelerator program on behalf of the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) and Smart City Works, an accelerator for early stage companies developing technology for the built environment. Mike began his career as a Research Associate at The Advisory Board Company in Washington, D.C. He holds a BA from the University of Michigan and an MA from American University.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Mike Ravenscroft invests in
Stages Mike Ravenscroft invests in
Countries Mike Ravenscroft invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (60%)
- AgTech 1 (20%)
- Travel 1 (20%)
- Leisure 1 (20%)
- Tourism 1 (20%)
Stage
- Series A 3 (60%)
- Seed 2 (40%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Impruvon Health is on a mission to improve the health of individuals with difficult to maintain medication regimens, living at home or in long-term care environments as well as the lives of those supporting them. They have worked extremely hard to tailor our solution to specific groups of individuals including those living with intellectualand/or developmental disabilities, those undergoing recovery from an addiction, and veterans Their platform automates medication management by eliminating the manual storage and administration processes as well as record keeping while aiding independence and security for the individual prescribed. Having experienced the detrimental impacts that medication errors can have on an individual and their family firsthand has given us a unique understanding of the technology required to stop errors, thefts, and overdoses while aiding medication compliance for individuals and their loved ones. | $2.4M / Seed / Jan 28, 2025 | ||
| Minnowtech is an aquaculture technology company, based in Baltimore, MD, that provides a software imaging platform to enable shrimp farmers to estimate shrimp abundance non-invasively with precision. Using Minnowtech’s data-based imaging tool, shrimp farmers optimize the health and growth of their hatcheries, enhancing the harvest of market-sizeshrimp while minimizing risks to juvenile shrimp. With the continued growth of aquaculture worldwide, Minnowtech addresses head-on the industry’s most acute challenge, which is overcoming limitations in how shrimp farmers assess the abundance, growth, and optimal harvest times of their crop. Minnowtech, via its low-cost technology and expert team of marine scientists, helps improve aquaculture farmers’ livelihoods while improving global food security and sustainability of marine environments. | Series A / Feb 26, 2024 | ||
| Linshom is first to deliver continuous respiratory monitoring, including Tidal Volume, to the patient bedside. | $2.2M / Series A / Aug 15, 2023 | ||
| Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria | $2M / Seed / Jun 05, 2023 | ||
| Marinalife provides premium content and valuable services for all types of boaters. The Marinalife Cruising Club membership offers boaters access to detailed marina information, travel resources including trip itineraries and destination guides to make their next boating adventure stress-free. In addition, the Marinalife magazine, a quarterlytravel and lifestyle publication, provides boaters with entertaining and useful articles about destinations, marinas, cruising stories, captain's tips and more. | Series A / Jan 25, 2023 |
Co-Investors
Launched in 2016 with a $10 million commitment from the University System of Maryland (USM), the Maryland Momentum Fund invests in USM-affiliated companies to support entrepreneurism, catalyze outside investment in early-stage startups, and foster economic development and technology commercialization. USM combines the power of its memberinstitutions provide students access to world-class resources and ensure that those resources are used efficiently, effectively, and sustainably.
University System of Maryland Momentum Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Claire Broido Johnson
Managing Director
|
|||
Leonard Raley
President and CEO; Vice Chancellor for Advancement
|
|||
Lindsay D'Ambrosio
Venture Development Director
|
|||
Michelle A. Gourdine
Secretary, Board of Regents
|
|||
Tina Williams
Cybersecurity Academic Innovation Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Mike Ravenscroft invest in?
Mike Ravenscroft invests primarily in Health Care, AgTech and Travel startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mike Ravenscroft?
Public channels for Mike Ravenscroft include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mike Ravenscroft last invest?
The most recent investment recorded for Mike Ravenscroft closed in Jan 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
